Cryptococcal meningitis in a patient with multiple sclerosis on dimethyl fumarate treatment: A case report

Mult Scler Relat Disord. 2020 Jul:42:102137. doi: 10.1016/j.msard.2020.102137. Epub 2020 Apr 29.

Abstract

Introduction: We present a case of meningitis caused by Cryptococcus neoformans var. grubii in a 46-year old non-HIV-infected patient with multiple sclerosis, treated with dimethyl fumarate monotherapy. We identified no other risk factors for developing cryptococcal meningitis. The patient presented with a slowly progressive headache during preceding weeks and acute onset of confusion, nausea and vomiting. Clinical examination revealed intermittent disorientation without focal neurological symptoms. A lumbar puncture showed an opening pressure of > 50cmH2O. Diagnosis of cryptococcal meningitis was made after culture of Cryptococcus neoformans var. grubii of cerebrospinal fluid.

Conclusion: This case emphasizes clinicians should bear in mind the possibility of cryptococcal meningitis in patients treated with dimethyl fumarate.

Keywords: Cryptococcal meningitis; Cryptococcus neoformans var. grubii; Dimethyl fumarate; Multiple sclerosis.

Publication types

  • Case Reports

MeSH terms

  • Cryptococcus neoformans / pathogenicity*
  • Dimethyl Fumarate / adverse effects*
  • Humans
  • Immunosuppressive Agents / adverse effects*
  • Male
  • Meningitis, Cryptococcal / diagnosis*
  • Meningitis, Cryptococcal / etiology*
  • Middle Aged
  • Multiple Sclerosis, Relapsing-Remitting / drug therapy*

Substances

  • Immunosuppressive Agents
  • Dimethyl Fumarate